Skip to main content

bupivacaine/meloxicam (Zynrelef®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Product meets AWMSG exclusion criterion 17. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

Medicine details

Medicine name bupivacaine/meloxicam (Zynrelef®)
Formulation prolonged-release wound solution
Reference number 4376
Indication

Treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults

Company Heron Therapeutics
BNF chapter Anaesthesia
Submission type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 28/09/2020
Follow AWTTC: